Butantan vaccine maintains 80.5% efficacy against severe dengue after 5 years
The dengue vaccine developed by the Butantan Institute continues to show 80.5% efficacy against severe cases of dengue after five years of study.
VIDEOS: Lunch Newspaper Florianópolis of Thursday, March 5, 2026
The article covers various criminal cases and political events in Brazil, including an ongoing investigation into allegations of corruption and a discussion regarding the dengue vaccine's efficacy.
G1 and TV Subaé videos - Thursday, March 5, 2026
Investigations and controversies emerge in Brazil, including a police inquiry about a prison suicide attempt, financial controversies involving political figures, and a discussion of vaccine efficacy.
Butantan's dengue vaccine maintains protection for five years and reduces severe cases, points out unprecedented study
A long-term analysis of the dengue vaccine developed by Butantan reveals that one dose provides at least five years of protection and significantly reduces severe disease cases.
What We Know About Shingles Vaccine and Dementia
Research shows that the shingles vaccine may reduce the risk of dementia, but uncertainty remains about its efficacy in safeguarding memory.
New study: booster vaccinations reduced severe consequences of COVID-19
A recent study published in the journal 'Vaccine' shows that booster vaccinations significantly decreased the incidence of severe COVID-19 outcomes, with similar efficacy found for Moderna and Pfizer/BioNTech boosters, though protection waned over time.
RFK Jr. cast doubt on a key vaccine. This country can't wait to get it
Health Secretary Robert F. Kennedy Jr. has raised concerns about the safety and efficacy of the hepatitis B vaccine, coinciding with the CDC's decision to reduce the number of vaccines recommended for children.